Table 3. Substance Use Disorder Diagnoses by Gender Among Transfeminine Individuals, Transmasculine Individuals, Cisgender Male Individuals, and Cisgender Female Individuals in the US, 2017.
| SUDD | Transgender, No. (%) | Bivariate comparison 1a | Cisgender, No. (%) | Bivariate comparison 2a | ||||
|---|---|---|---|---|---|---|---|---|
| Transfeminine (n = 2079) | Transmasculine (n = 4955) | χ2 | P value | Male (n = 23 247) | Female (n = 23 664) | χ2 | P value | |
| Polysubstance | 49 (2.4) | 39 (0.8) | 29.2 | <.001 | 159 (0.7) | 87 (0.4) | 22.5 | <.001 |
| Nicotine | 335 (16.1) | 551 (11.1) | 33.2 | <.001 | 1272 (5.5) | 1279 (5.4) | 0.1 | .75 |
| Alcohol and drug | 114 (5.5) | 161 (3.2) | 19.5 | <.001 | 476 (2) | 344 (1.5) | 24.1 | <.001 |
| Alcohol | 53 (2.5) | 56 (1.1) | 19.3 | <.001 | 283 (1.2) | 155 (0.7) | 40.1 | <.001 |
| Drug | 91 (4.4) | 123 (2.5) | 17.8 | <.001 | 308 (1.3) | 241 (1) | 9.5 | .002 |
| Cannabis | 48 (2.3) | 42 (0.8) | 24.8 | <.001 | 114 (0.5) | 72 (0.3) | 10.3 | .001 |
| Cocaine | 18 (0.9) | <11 (0.3)b | >14.8 | <.001 | 35 (0.2) | 24 (0.1) | 2.3 | .13 |
| Opioid | 23 (1.1) | 51 (1.0) | 0.1 | .77 | 109 (0.5) | 98 (0.4) | 0.8 | .37 |
| Another drugc | 31 (1.5) | 40 (0.8) | 6.9 | .01 | 105 (0.45) | 78 (0.3) | 4.5 | .03 |
Abbreviation: SUDD, substance use disorder diagnoses.
a
Using χ2 analyses, bivariate comparisons compare within-group differences in each SUDD category between transfeminine and transmasculine individuals (1) and cisgender male and female individuals (2).
b
To protect the confidentiality of individuals, exact values are not reported.
c
Another drug SUDD includes hallucinogens, sedatives, stimulants, and the diagnosis of other SUD not otherwise specified.